These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2871741)

  • 1. Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors.
    Neve KA; Molinoff PB
    Am J Cardiol; 1986 Apr; 57(12):17F-22F. PubMed ID: 2871741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of drugs on beta-adrenergic receptors on human lymphocytes.
    Molinoff PB; Aarons RD
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S63-7. PubMed ID: 6188922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats.
    Nanoff C; Ströher M; Haschkowitz H; Schütz W; Pittner H
    Basic Res Cardiol; 1990; 85(1):88-95. PubMed ID: 1970235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down regulation of beta adrenergic receptors in S49 lymphoma cells induced by atypical agonists.
    Reynolds EE; Molinoff PB
    J Pharmacol Exp Ther; 1986 Dec; 239(3):654-60. PubMed ID: 2879029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.
    Joseph SS; Lynham JA; Molenaar P; Grace AA; Colledge WH; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):496-503. PubMed ID: 14608456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of celiprolol.
    Louis WJ; Drummer OH; Tung LH
    Cardiovasc Drugs Ther; 1991 Jan; 4 Suppl 6():1281-5. PubMed ID: 1672604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac effects of beta-adrenoceptor antagonists with intrinsic sympathomimetic activity in humans: beta1- and/or beta2-adrenoceptor mediated?
    Jakubetz J; Schmuck S; Poller U; Fuchs B; Gorf A; Radke J; Pönicke K; Brodde OE
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):461-72. PubMed ID: 10069683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD; Cobuzzi A; Wolf PS; Pruss TP
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between beta adrenoceptor occupancy and receptor down-regulation induced by beta antagonists with intrinsic sympathomimetic activity.
    Lima JJ
    J Recept Signal Transduct Res; 1996; 16(5-6):357-72. PubMed ID: 8968966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol.
    Homburger V; Gozlan H; Bouhelal R; Lucas M; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):279-87. PubMed ID: 2858822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
    Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo.
    Conway PG; Tejani-Butt S; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Jun; 241(3):755-62. PubMed ID: 2885407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of partial agonist activity in man and its therapeutic relevance.
    Carruthers SG
    Arq Bras Cardiol; 1984 Mar; 42(3):223-5. PubMed ID: 6148056
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.
    Kaumann AJ; Molenaar P
    Br J Pharmacol; 1996 Aug; 118(8):2085-98. PubMed ID: 8864547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.